Open access
Aug 2026
Harnessing reverse vaccinology for the design and validation of mRNA vaccine targeting the glycoprotein of human metapneumovirus (HMPV)
The two proposed multi-epitope mRNA vaccine constructs showed promising immunogenic, safety, and structural properties in silico, highlighting their potential as candidate vaccines against HMPV.
E. K. Oladipo, James Akinwumi Ogunniran, Oluwaseyi Samuel Akinpelu et al.
· Discover Immunity · 0 citations